What is a GLP-1, exactly
Healthcare providers use a combination of patient history, physical exams, and lab tests to confirm the presence of an infection and determine the most effective treatment
The combined treatment demonstrated significantly greater efficacy than standard-dose pregabalin or acetyl-l-carnitine alone, in terms of both pain symptoms measured by improvement on the VAS score (+12.8%) and neurosensory symptoms measured by the DN4 tool (+22%)
W., Ouyang, K., Anzala, O., Ogengo, J
Human trials employing standardized extracts (e.g., SHR-5) at doses ranging from 200 to 680 mg/day have reported a low incidence of adverse events, primarily mild and transient symptoms such as dizziness, dry mouth, or gastrointestinal discomfort
Its epidemiology shows marked geographic variation: incidence is highest in North America and Western Europe (920 cases per 100,000 person-years) but is rising rapidly in regions historically considered low risk, including parts of Asia and South America (Hracs et al., 2025